-
EP2187948
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2187948
| EP2187948 - USE OF A PEPTIDE AS A THERAPEUTIC AGENT [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 24.08.2012 Database last updated on 13.07.2024 | Most recent event Tooltip | 24.08.2012 | Application deemed to be withdrawn | published on 26.09.2012 [2012/39] | Applicant(s) | For all designated states Mondobiotech Laboratories AG Herrengasse 21 9490 Vaduz / LI | [2010/21] | Inventor(s) | 01 /
BEVEC, Dorian Kriegerstrasse 62 82110 Germering / DE | 02 /
CAVALLI, Fabio Via Pasquée 23 CH-6925 Gentilino / CH | 03 /
CAVALLI, Vera Via Pasquée 23 CH-6925 Gentilino / CH | 04 /
BACHER, Gerald Masurenweg 5 82110 Germering / DE | [2010/21] | Representative(s) | Arth, Hans-Lothar ABK Patent Attorneys Jasminweg 9 14052 Berlin / DE | [N/P] |
| Former [2010/21] | Arth, Hans-Lothar ABK Patent Attorneys Jasminweg 9 14052 Berlin / DE | Application number, filing date | 08802129.0 | 09.09.2008 | [2010/21] | WO2008EP07577 | Priority number, date | EP20070017756 | 11.09.2007 Original published format: EP 07017756 | [2010/21] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2009033714 | Date: | 19.03.2009 | Language: | EN | [2009/12] | Type: | A2 Application without search report | No.: | EP2187948 | Date: | 26.05.2010 | Language: | EN | The application published by WIPO in one of the EPO official languages on 19.03.2009 takes the place of the publication of the European patent application. | [2010/21] | Search report(s) | International search report - published on: | EP | 03.09.2009 | Classification | IPC: | A61K38/26, A61P3/00, A61P9/00, A61P11/00, A61P25/28, A61P31/00, A61P35/00, A61P37/00 | [2010/21] | CPC: |
A61K38/23 (EP,US);
A61P1/00 (EP);
A61P1/02 (EP);
A61P1/04 (EP);
A61P1/16 (EP);
A61P11/00 (EP);
A61P11/02 (EP);
A61P11/06 (EP);
A61P11/08 (EP);
A61P13/12 (EP);
A61P15/00 (EP);
A61P15/08 (EP);
A61P17/00 (EP);
A61P17/02 (EP);
A61P17/04 (EP);
A61P17/06 (EP);
A61P19/00 (EP);
A61P19/02 (EP);
A61P19/04 (EP);
A61P19/06 (EP);
A61P19/08 (EP);
A61P19/10 (EP);
A61P21/00 (EP);
A61P25/00 (EP);
A61P25/02 (EP);
A61P25/24 (EP);
A61P25/28 (EP);
A61P27/02 (EP);
A61P29/00 (EP);
A61P3/00 (EP);
A61P3/02 (EP);
A61P3/04 (EP);
A61P3/06 (EP);
A61P3/10 (EP);
A61P31/00 (EP);
A61P31/04 (EP);
A61P31/12 (EP);
A61P31/18 (EP);
A61P31/20 (EP);
A61P33/06 (EP);
A61P35/00 (EP);
A61P35/02 (EP);
A61P35/04 (EP);
A61P37/00 (EP);
A61P37/02 (EP);
A61P37/06 (EP);
A61P37/08 (EP);
A61P39/06 (EP);
A61P5/00 (EP);
A61P5/14 (EP);
A61P5/30 (EP);
A61P7/12 (EP);
A61P9/00 (EP);
A61P9/04 (EP);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR [2010/21] | Title | German: | VERWENDUNG EINES PEPTIDS ALS THERAPEUTISCHES MITTEL | [2010/21] | English: | USE OF A PEPTIDE AS A THERAPEUTIC AGENT | [2010/21] | French: | UTILISATION D'UN PEPTIDE COMME AGENT THÉRAPEUTIQUE | [2010/21] | Entry into regional phase | 05.03.2010 | National basic fee paid | 05.03.2010 | Designation fee(s) paid | 05.03.2010 | Examination fee paid | Examination procedure | 05.03.2010 | Amendment by applicant (claims and/or description) | 05.03.2010 | Examination requested [2010/21] | 28.12.2010 | Despatch of a communication from the examining division (Time limit: M04) | 15.04.2011 | Reply to a communication from the examining division | 03.04.2012 | Application deemed to be withdrawn, date of legal effect [2012/39] | 07.05.2012 | Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2012/39] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 28.12.2010 | Fees paid | Renewal fee | 21.08.2010 | Renewal fee patent year 03 | Penalty fee | Additional fee for renewal fee | 30.09.2011 | 04 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [XY]WO0224214 (OSTEOMETER BIOTECH AS [DK], et al) [X] 1,6,8-15 * page 17, line 28 - page 18, line 9; example -; claim - * [Y] 1-15; | [XY]WO2006122981 (NOVO NORDISK AS [DK], et al) [X] 1,6,8-15 * page 27, line 22 - page 36, line 3; figure -; claim - * * page 12, line 8 - line 26 * [Y] 1-12,1-15; | [XY]WO02066511 (CONJUCHEM INC [CA], et al) [X] 1,6,8-15 * claim - * [Y] 1-15; | [Y]WO2005082404 (NOVO NORDISK AS [DK], et al) [Y] 1,6,8-15,1-15 * page 13, line 23 - page 14, line 7; example -; claim 13 * * page 12, line 1 - line 10 * | [Y] - REUBI JEAN CLAUDE ET AL, "Candidates for peptide receptor radiotherapy today and in the future", JOURNAL OF NUCLEAR MEDICINE, (200501), vol. 46, no. Suppl. 1, ISSN 0161-5505, pages 67S - 75S, XP009114571 [Y] 1-15 * abstract * | [A] - THOMAS ROBERT P ET AL, "Role of gastrointestinal hormones in the proliferation of normal and neoplastic tissues.", ENDOCRINE REVIEWS, (200310), vol. 24, no. 5, ISSN 0163-769X, pages 571 - 599, XP002523152 [A] * page 576, column 1 - page 577, column 2 * * page 580, column 2 - page 581, column 2 * DOI: http://dx.doi.org/10.1210/ER.2002-0028 | [Y] - BIRON ET AL, "Antiviral drugs for cytomegalovirus diseases", ANTIVIRAL RESEARCH, ELSEVIER SCIENCE BV., AMSTERDAM, NL, vol. 71, no. 2-3, ISSN 0166-3542, (20060901), pages 154 - 163, (20060901), XP025031402 [Y] 1-15 * the whole document * DOI: http://dx.doi.org/10.1016/j.antiviral.2006.05.002 | [Y] - TANIKAWA K, "Recent advances in antiviral agents: Antiviral drug discovery for hepatitis viruses", CURRENT PHARMACEUTICAL DESIGN, (2006), vol. 12, no. 11, ISSN 1381-6128, pages 1371 - 1377, XP002531343 [Y] 1-15 * the whole document * DOI: http://dx.doi.org/10.2174/138161206776361165 | by applicant | WO9729782 |